MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
-5.58%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$360M
AUM Growth
+$360M
(-3.4%)
Cap. Flow
+$20.9M
Cap. Flow
% of AUM
5.8%
Top 10 Holdings %
Top 10 Hldgs %
69.65%
Holding
41
New
4
Increased
3
Reduced
1
Closed
4
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$13.2M |
| 2 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$11.6M |
| 3 |
Intellia Therapeutics
NTLA
|
$7.25M |
| 4 |
Geron
GERN
|
$3.54M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$3.22M |
Top Sells
| 1 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$9.43M |
| 2 |
Axsome Therapeutics
AXSM
|
$4.13M |
| 3 |
Relmada Therapeutics
RLMD
|
$3.73M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$3.68M |
| 5 |
Cytokinetics
CYTK
|
$1.18M |
Sector Composition
| 1 | Healthcare | 100% |
